CERO THERAPEUTICS HOLDINGS, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CERO THERAPEUTICS HOLDINGS, INC. payments for repurchase of common stock for the quarter ending 2023-12-31 was $27.84M.
- CERO THERAPEUTICS HOLDINGS, INC. payments for repurchase of common stock for fiscal 2023 was $33.48M, a 75.97% decline from fiscal 2022.
- CERO THERAPEUTICS HOLDINGS, INC. payments for repurchase of common stock for fiscal 2022 was $139.35M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2023-12-31 | $27.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | $33.48M 10-K · filed 2024-04-02 |
| 2022-12-31 | $139.35M 10-K · filed 2024-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |